| NCT Number | NCT07237685 |
| Lead Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators: Horizon Innovative Health Initiative, Novo Nordisk A/S, INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA (IBSAL), Cardiology Centers of the Netherlands |
| Conditions | Type 2 Diabetes, Coronary Artery Disease (CAD), Atherosclerosis Cardiovascular Disease |
| Enrollment | 1,000 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2026-10-01 (estimated) |
| Study Completion | 2036-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-11-20 |